20 results on '"Svedbom A"'
Search Results
2. Mind the gap: Incidence of osteoporosis treatment after an osteoporotic fracture – results of the Austrian branch of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)
3. The long-term impact of multiple sclerosis on the risk of divorce
4. Personal Income Before and After Diagnosis of Multiple Sclerosis
5. Itch Is More Important than Clinical Disease Severity for Depression in Psoriasis: A Prospective Register Study
6. Risk of respiratory infection in patients with plaque psoriasis
7. Interaction between Smoking and HLA-C*06:02 on the Response to Ustekinumab in Psoriasis
8. POSA386 Costs of Hospital Care and Productivity Loss Due to Sickle Cell Disease in Sweden: A Retrospective Study
9. PMS67 EXPERIENCE AND PREFERENCE-BASED EQ-5D-3L VALUE SET DERIVED FROM LONGITUDINAL DATA: RESULTS FROM THE INTERNATIONAL COSTS AND UTILITIES OF OSTEOPOROTIC FRACTURES STUDY (ICUROS)
10. 340 Circulating microRNAs in extracellular vesicles from plasma as potential biomarkers for psoriatic arthritis in patients with psoriasis
11. PSS35 - Cost-Effectiveness Analysis of Ixekizumab vs. Secukinumab in Sequential Biologic Treatment of Psoriasis in the UK
12. PMS75 - Accumulated one Year Health Utility Loss After Sustaining A Hip Fracture In Mexico
13. Sociodemographic Factors Associated to Health-Related Quality of Life Among Patients With Osteoporotic Fractures in Mexico
14. PMS44 - Resource Use Related To Vertebral Fractures Based On Data From Icuros
15. PMS105 - The Resource Use Related to Hip Fractures Based on Data from ICUROS
16. PMS61 Health-Related Quality of Life After Vertebral Fracture: Differences Between the EQ-5D and Time-Trade-Off Instruments
17. Epidemiology of humeral fractures in Austria between 1989 and 2008
18. PMS25 COST-EFFECTIVENESS IN OSTEOARTHRITIS PAIN RELIEF TREATMENT WITH NSAIDS – A DETERMINATION AND ESTIMATION OF KEY DRIVERS
19. PMS18 ESTIMATION OF COSTS RELATED TO ADVERSE EVENTS IN NSAID TREATMENT OF OSTEOARTHRITIS – A COMPARISON BETWEEN CELECOXIB AND IBUPROFEN USING A VALIDATED MODEL
20. PMS47 POTENTIAL HEALTH ECONOMIC BENEFITS OF IMPROVING THE CARDIOVASCULAR SAFETY PROFILE OF NSAIDS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.